Response to neoadjuvant chemotherapy in ICON8: A GCIG phase III randomised trial evaluating weekly dose-dense chemotherapy integration in first-line epithelial ovarian/ fallopian tube/ primary peritoneal carcinoma (EOC) treatment

Research output: Contribution to journalArticlepeer-review

Authors

  • A. R. Clamp
  • I. A. McNeish
  • A. Dean
  • D. Gallardo-Rincon
  • J. W. Kim
  • D. M. O'Donnell
  • J. Hook
  • S. Blagden
  • J. D. Brenton
  • R. Naik
  • T. J. Perren
  • A. D. Cook
  • E. C. James
  • H. Gabra
  • R. Lord
  • M. Hall
  • G. Dark
  • R. S. Kaplan
  • J. A. Ledermann

Colleges, School and Institutes

External organisations

  • Christie Hospital NHS Foundation Trust
  • Imperial College London
  • Saint John of God Hospital Subiaco
  • Instituto Nacional de Cancerología
  • SEOUL NATIONAL UNIVERSITY INDUSTRY - ACADEMIC COOPERATION FOUNDATION
  • Medical Oncology
  • Leeds Teaching Hospitals Trust
  • University of Oxford
  • University of Cambridge
  • Gateshead Health NHS Foundation Trust
  • Pan-Birmingham Gynaecological Cancer Centre
  • UCL
  • Gloucestershire Hospitals NHS Foundation Trust
  • Mount Vernon Hospital
  • Newcastle University

Details

Original languageEnglish
Pages (from-to)viii336
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Volume29
Publication statusPublished - 1 Oct 2018

ASJC Scopus subject areas